Stay updated on Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision was updated to v3.5.4 from v3.5.3, signaling a maintenance update to the page content. This change represents an administrative refresh rather than a substantive alteration to the study record.
    Difference
    0.0%
    Check dated 2026-05-14T23:03:49.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    - The page now shows Revision: v3.5.3, replacing the earlier Revision: v3.5.2. This is a minor page/document revision update and does not modify study data or functionality.
    Difference
    0.0%
    Check dated 2026-04-30T16:27:48.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T09:57:06.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision notes updated: added 'Revision: v3.5.0' and removed 'Revision: v3.4.3'.
    Difference
    0.0%
    Check dated 2026-03-25T20:13:27.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3 (replacing the previous v3.4.2).
    Difference
    0.0%
    Check dated 2026-03-11T14:05:12.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Added Primary peritoneal carcinoma to the study conditions and a Resources link for the Genetic and Rare Diseases Information Center. Updated page revision to v3.4.2 and removed the government funding lapse notice along with the previous revision note v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-11T02:48:41.000Z thumbnail image

Stay in the know with updates to Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.